Among these, connective tissue growth factor (CTGF) plays an auxiliary role in gliomas by activating the ITGB1-TrkA-NF-kB pathway, which can inhibit E-cadherin at the transcription level and enhance the invasion and migration of glioma cells (Edwards et al., 2011). This evidence concerns the gene CCN2 and central nervous system cancer.